KINERET

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug KINERET contains one active pharmaceutical ingredient (API):

1 Recombinant human interleukin-1 receptor antagonist
UNII 9013DUQ28K - ANAKINRA

Anakinra neutralises the biologic activity of interleukin-1α (IL-1α) and interleukin-1β (IL-1β) by competitively inhibiting their binding to interleukin-1 type I receptor (IL-1RI). Interleukin-1 (IL-1) is a pivotal pro-inflammatory cytokine mediating many cellular responses including those important in synovial inflammation.

Read about Anakinra

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
KINERET Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AC03 Anakinra L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10263E, 10264F
Country: CA Health Products and Food Branch Identifier(s): 02245913
Country: EE Ravimiamet Identifier(s): 1198661, 1198728, 1198739, 1633799, 1633801, 1633812
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 102203006
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 373254, 418642
Country: FR Base de données publique des médicaments Identifier(s): 60663231
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 361080
Country: IE Health Products Regulatory Authority Identifier(s): 88936
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6665
Country: IT Agenzia del Farmaco Identifier(s): 035607011, 035607023, 035607035, 035607047, 035607050, 035607062, 035607074
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029083, 1029084, 1029085, 1074113, 1074114, 1074115
Country: NL Z-Index G-Standaard Identifier(s): 15140237
Country: NL Z-Index G-Standaard, PRK Identifier(s): 67385
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100126933
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W53719001, W53719002, W53719003, W53720001
Country: US FDA, National Drug Code Identifier(s): 66658-234

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.